Abstract
Resident cells of tissues are capable of secreting an array of structurally related zinc endopeptidases known as matrix metalloproteinases (MMPs). They initiate the degradation of the surrounding macromolecules of the extracellular matrix (ECM), mostly proteoglycans and specific types of collagen. ECM degradation presumably contributes to the initial phase of tissue remodeling inherent to the physiological processes of morphogenesis, angiogenesis, involution of the uterus, bone resorption, inflammation, and wound healing. The aberrant activity of MMPs has been found to be involved in a variety of pathological processes, e.g., rheumatoid joint destruction, corneal ulceration, metastasis of tumor cells, and various genetic diseases (1,2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Matrisian L. M. (1992) The matrix degrading metalloproteinases. Bioessays 14, 455–463.
Birkedal-Hansen H., Moore W. G. I., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., and Engler J. A. (1993) Matrix metalloproteinase. A review. Crit. Rev. Oral. Biol. Med. 4, 197–250.
Dioszegi M., Cannon P., and van Wart H. (1995) Verterbrate collagenases. Methods Enzymol. 248, 413–431.
Sang Q. A. and Douglas D. A. (1996) Computational sequence analysis of matrix metalloproteinases. J. Protein Chem. 15, 137–160.
Murphy G. and Willenbrock F. (1995) Tissue inhibitors of metalloendopep-tidases. Methods Enzymol. 248, 496–510.
Greene J., Wang M., Raymond L. A., Liu Y. E., Rosen C., and Shi Y. E. (1996) TIMP-4, a novel human tissue inhibitor of metalloproteinase, was identified and cloned. J. Biol. Chem. 271, 30,375–30,380.
Angel P. and Karin M. (1991) The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta. 1072, 129–157.
Vincenti M. P., White L. A., Schrön D. J., Benbow U., and Brinckerhoff C. E. (1996) Regulating expression of the gene for matrix metalloproteinase-1 (colla-genase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit. Rev. Eukaryot. Gene Expr. 6(4), 391–411.
Borden P. and Heller R. A. (1997) Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7(1–2), 159–178.
Docherty A.J., O’Connell J., Crabbe T., Angal S., and Murphy G. (1992) The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol. 10(6), 200–207.
O’Hare M. C., Clarke N. J., and Cawston T. E. (1992) Production in Escherichia coli of porcaine type I collagenase as a fusion protein with β-galactosidase. Gene 111, 245–248.
Housley T. J., Baumann A. B., Braun I. D., Davis G., Seperack P. K., and Wilhelm S. M. (1993) Recombinant Chinese hamster ovary cell matrix metallo-protease-3 (MMP-3, stromelysin-1). Role of calcium in promatrix metal-loprotease-3 (pro-MMP-3, prostromelysin-1) activation and thermostability of the low mass catalytic domain of MMP-3. J. Biol. Chem. 268(6), 4481–4487.
Windsor L. J., Bodden M. K., Birkedal-Hansen B., and Engler J. A., and Bir-kedal-Hansen H. (1994) Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J. Biol. Chem. 269, 26,201–26,207.
Freimark B. D., Feeser W. S., and Rosenfeld S. A. (1994) Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme. J. Biol. Chem. 269(43), 26,982–26,987.
Rosenfeld S. A., Ross O. H., Hillman M. C., Corman J. I., and Dowling R. L. (1996) Production and purification of human fibroblast collagenase (MMP-1) expressed in the methylotrophic yeast Pichia pastoris. Protein Expr. Purif. 7(4), 423–430.
Zhang Y. and Gray R. D. (1996) Characterization of folded, intermediate, and unfolded states of recombinant human interstitial collagenase. J. Biol. Chem. 271(14), 8015–80211.
Knäuper V., Cowell S., Smith B., López-Otin C., O’Shea M., Morris H., Zardi L., and Murphy G. (1997) The role of C-terminal domain of human colla-genase-3 (MMP-13) in the activation of procollagenase-3 substrate specificity and tissue inhibitor of metalloproteinse interaction. J. Biol. Chem. 272(12), 7608–7616.
Lemaitre V., Jungbluth A., and Eeckhout Y. (1997) The recombinant catalytic domain of mouse collagenase-3 depolymerizes type I collagen by cleavingits aminotelopeptides. Biochem. Biophys. Res. Commun. 230(1), 202–205.
Gomez D. E., Lindsay C. K., Cottam D. W., Nason A. M., and Thorgeirsson U. P. (1994) Expression and characterization of human tissue inhibitor of metalloproteinases-1 in a baculovirus-insect cell system. Biochem. Biophys. Res. Commun. 203(1), 237–243.
Cocuzzi E. T., Walther S. E., and Denhardt D. T. (1994) Expression and secretion of active mouse TIMP-1 using a baculovirus expression vector. Inflammation 18(1), 35–43.
Bergmann U., Tuuttila A., Stetler-Stevenson W. G., and Tryggvason K. (1995) Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry 34(9), 2819–2825.
Kurschat P., Graeve L., Erren A., Gatsios P., Rose-John S., Roeb E., Tschesche H., Koj A., and Heinrich P. C. (1995) Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus-infected insect cells. Purification and tissue distribution in the rat. Eur. J. Biochem. 234(2) 485–491.
Vallon R., Müller R., Moosmayer D., Gerlach E., and Angel P. (1997) The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1). Eur. J. Biochem. 244(1), 81–88.
Liu Y. E., Wang M., Greene J., Su J., Ullrich S., Li H., Sheng S., Alexander P., Sang Q. A., and Shi Y. E. (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J. Biol. Chem. 272(33) 20,479–20,483.
Whitham S. E., Murphy G., Angel P., Rahmsdorf H. J., Smith B. J., Lyons A., Harris T. J. Reynolds J. J., Herrlich P., and Docherty A. (1986) Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J. 240, 913–916.
Annweiler A., Hipskind R. A., and Wirth T. (1991) A strategy for efficient in vitro translation using the rabbit β-globin leader sequence. Nucleic Acids Res. 19, 3750.
Angel P. Hattori K., Smeal T., and Karin M. (1988a) The Jun proto-oncogene is positively autoregulated by its product, Jun/AP1. Cell 55, 875–885.
Docherty A. J. P., Lyons A., Smith B. J., Wright E. M., Stephens P. E., Harris T. J. R., Murphy G., and Reynolds J. J. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318, 66–69.
Angel P., Allegretto E. A., Okino S., Hattori K., Boyle W. J., Hunter T., and Karin M. (1988) Oncogene Jun encodes a sequence specific trans-activator similar to AP1. Nature 332, 166–171.
Reed L. J. and Muench H. (1938). A simple method of estimating fifty percent endpoints. Amer. J. Hygiene 27, 493–497.
Springman E. B., Angleton E. L., Birkedal-Hansen H., and van Wart H. E. (1990) Multiple modes of activation of latent human fibroblast collagenase. Evidence for the role of a Cys-73 active-size zinc complex in latency and a “cysteine switch” mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364–368.
Cawston T. E. and Murphy G. (1981) Mammalian collagenase. Methods Enzymol. 80, 711–722.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Vallon, R., Angel, P. (2001). Expression of Human Collagenase I (MMP-1) andTIMP-1 in a Baculovirus-Based Expression System. In: Clark, I.M. (eds) Matrix Metalloproteinase Protocols. Methods in Molecular Biology™, vol 151. Humana Press. https://doi.org/10.1385/1-59259-046-2:207
Download citation
DOI: https://doi.org/10.1385/1-59259-046-2:207
Publisher Name: Humana Press
Print ISBN: 978-0-89603-733-5
Online ISBN: 978-1-59259-046-9
eBook Packages: Springer Protocols